SCHEMBL7811522

SCHEMBL7811522

O=C(O)CC(Oc1ccccc1)C1CCN(C(=O)c2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
ALDH1A1 P00352 1/20 0.47
HTT P42858 2/20 0.47
EPHX1 P07099 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KCNA5 P22460 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HPGD P15428 1/20 0.44
GRM5 P41594 1/20 0.44
GAA P10253 1/20 0.44
ADAM17 P78536 1/20 0.43
MGLL Q99685 1/20 0.43
HSD11B1 P28845 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811501 0.92 KMT2A (0.47) ACHEHTTL3MBTL3L3MBTL1KMT2A
SCHEMBL7811611 0.88 NPC1 (0.56) ALDH1A1HTTL3MBTL3L3MBTL1KMT2A
SCHEMBL7817608 0.83 ALDH1A1 (0.50) ALDH1A1HTTKMT2AMEN1KDM4E
SCHEMBL7817804 0.77 NPC1 (0.54) ALDH1A1HTTL3MBTL3L3MBTL1HPGD
SCHEMBL7817391 0.76 MAOB (0.54) ALDH1A1KCNA5BLMKMT2AMEN1
SCHEMBL7804380 0.74 KCNA5 (0.52) ACHEALDH1A1HTTEPHX1L3MBTL3
SCHEMBL7810120 0.73 POLB (0.48) ACHEALDH1A1HTTKCNA5BLM
SCHEMBL2603247 0.73 ACHE (0.68) ACHEALDH1A1EPHX1L3MBTL3L3MBTL1
SCHEMBL14597201 0.72 ACHE (0.61) ACHEALDH1A1HTTEPHX1L3MBTL3
SCHEMBL7320518 0.72 ACHE (0.66) ACHEALDH1A1EPHX1L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
CN-1035178-C Arylamide derivatives SS PHARMACEUTICAL CO (JP) 1997-06-18 CN disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
CN-1094039-A Arylamide derivatives SS PHARMACEUTICAL CO (JP) 1994-10-26 CN disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed